Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
InductOs (dibotermin alfa) - Important Safety Information from Wyeth Pharmaceuticals as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
29/03/2007
Problem Or Issue:
Please find attached Safety Communication from Wyeth Pharmaceuticals on the association of InductOs (dibotermin alfa) with reports of fluid collections (e.g. pseudocysts, localised oedema, implant site effusion) sometimes encapsulated, in patients receiving InductOs for spinal procedures, regularly requiring intervention.
« Back
Date Printed: 20/04/2024